Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments and tissue injury caused by non-cancerous conditions. The new test ...

SeekIn has announced the clinical validation of its SeekInCare blood test, intended for the early identification of various ...

They have developed a blood-based method called RARE-seq that detects tumor-derived cell-free RNA with around 50 ... outperforming commonly used DNA-based approaches. RNA from vaccines and many ...

This so-called cell free DNA can be used to identify cancer at very early stages. In a breakthrough, scientists have now developed a method for detecting small amounts of cell-free RNA. When a cell is ...

An artificial intelligence technique for detecting DNA fragments shed by tumors and circulating in a patient’s blood, ...

A groundbreaking study published in the Journal of Molecular Diagnostics reports the successful clinical validation of SeekInCare ®, a novel, non-invasive multi-omics blood test designed for the early ...

Mr George Nita, a General Surgery Registrar and doctoral candidate in Bioinformatics at the University of Liverpool, is ...

For the new cell-free DNA testing, a small amount of a person’s blood is tested for a large number of cancers. A positive test could indicate that the person has a certain type of cancer in ...

Researchers from The University of Texas MD Anderson Cancer Center have identified a new biomarker, TTF-1, that was ...

Collectively, the data presented here suggest that the PhasED-Seq-based MRD assay is accurate and reproducible, making it appropriate for use in the ...